Celanese vs Eastman Chemical
Celanese reported revenue of $9.5 billion in fiscal 2025, about the same as Eastman Chemical's $8.8 billion in fiscal 2025. Celanese's revenue fell 7.0% in its latest year, and Eastman Chemical's fell 6.7%. Free cash flow was $803 million at Celanese and $424 million at Eastman Chemical.
Side by side
| Celanese | Eastman Chemical | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $9.5B | $8.8B |
| Revenue growth | −7.0% | −6.7% |
| Revenue growth a year, last 5 years | 11.0% | 0.7% |
| Gross margin | 20.4% | 21.1% |
| Operating margin | −8.2% | — |
| Net margin | −12.2% | 5.4% |
| Free cash flow | $803M | $424M |
| Free cash flow margin | 8.4% | 4.8% |
| Return on capital | −3.7% | 6.5% |
| Net debt to EBITDA | — | 3.3x |
| Dividends and buybacks | $13M | $381M |
| Change in diluted share count | 0.2% | −1.9% |
| Last close | $48.08 | $65.73 |
| P/E at the last close | — | 17.1× |
| Insider trades, last 12 months | bought $593,258, sold $0 | sold $365,789 |
| Piotroski F-score | 5 of 9 | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CelaneseEastman Chemical
Operating margin
Percent of revenue
CelaneseEastman Chemical
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CelaneseEastman Chemical
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Celanese and Eastman Chemical pages.